Michael Bush is a biotech professional currently serving as the Central Europe & Rare Disease Pricing Lead at Sanofi. They possess a diverse background in global analytics, customer relations, insurance reimbursement, account management, and finance. Michael has several years of experience in accounts receivable and government pricing, focusing on Rare Genetic Diseases, End Stage Renal Disease, and Multiple Sclerosis. They previously held roles such as Global Pricing Lead for Multiple Sclerosis and Accounts Receivable & Revenue Manager at Genzyme Biosurgery. Michael earned a Bachelor of Science degree from Salem State University.
This person is not in any teams
This person is not in any offices